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Background
The dosing of vancomycin and gentamicin relies largely on
the weight and renal function of a patient. Due to their
narrow therapeutic index, these drugs also require thera-
peutic drug monitoring (TDM) during treatment to ensure
efficacy, reduce potential for oto- and nephro- toxicity,
and reduce potential for resistance. Guidelines for the use
of vancomycin and gentamicin, as well as a dosing calcula-
tor, is in place in CHB. This audit was performed around
the appropriate prescribing and monitoring of these two
antibiotics in CHB and findings were compared to similar
audits carried out in 2010 and 2012.
Methods
The audit was conducted over two weeks in CHB in June
2014. Patients receiving vancomycin and/or gentamicin
were identified from TDM ‘levels’ that had been requested
in the Biochemistry Laboratory, CHB. Clinical indication,
initial dosing, point in therapy at which first level was
taken, and action taken on first level were examined for
both drugs.
Results
A total of 20 patients were audited, 10 patients prescribed
vancomycin and 10 patients prescribed gentamicin. 100%
of patients were prescribed vancomycin for an appropriate
indication and 90% of patients were prescribed gentamicin
for an appropriate indication. Appropriate initial dose
(based on creatinine clearance and dosing calculator) for
vancomycin and gentamicin was 40% and 30% respec-
tively. Checking of the first serum level at the correct
point in therapy was 30% for both vancomycin and
gentamicin; whilst appropriate action based on this first
level was 78% for vancomycin and 66% for gentamicin.
Conclusions
Although the number of patients included in the audit is
small, further improvements in dosing and monitoring of
patients prescribed vancomycin and gentamicin in CHB
are required. Planned interventions include further educa-
tion sessions to increase awareness of the dosing calculator
and demonstration of its use, revision of the dosing
algorithms in the 2015 CHB antibiotic guidelines, and
development of a mobile phone application for calculating
initial dose requirements.
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